PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular Immunology and Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, 9747AG Groningen, The Netherlands.\', \'Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
  • E3010.3390/cells10010030
?:doi
?:hasPublicationType
?:journal
  • Cells
is ?:pmid of
?:pmid
?:pmid
  • 33375410
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.742
?:rankingScore_hIndex
  • 14
is ?:relation_isRelatedTo_publication of
?:title
  • The PIKfyve Inhibitor Apilimod: A Double-Edged Sword against COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33375410>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33375410>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all